0001013594-24-000191.txt : 20240214
0001013594-24-000191.hdr.sgml : 20240214
20240214161316
ACCESSION NUMBER: 0001013594-24-000191
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
EFFECTIVENESS DATE: 20240214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lion Point Capital, LP
CENTRAL INDEX KEY: 0001643354
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1230
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17316
FILM NUMBER: 24638275
BUSINESS ADDRESS:
STREET 1: 250 WEST 55TH STREET
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-356-6200
MAIL ADDRESS:
STREET 1: 250 WEST 55TH STREET
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001643354
XXXXXXXX
12-31-2023
12-31-2023
false
Lion Point Capital, LP
250 WEST 55TH STREET
33RD FLOOR
NEW YORK
NY
10019
13F HOLDINGS REPORT
028-17316
000174322
801-81004
N
Irshad Karim
General Counsel and Chief Compliance Officer
212-356-6200
/s/ Irshad Karim
New York
NY
02-14-2024
0
30
199864988
INFORMATION TABLE
2
informationtable.xml
AADI BIOSCIENCE INC
COM
00032Q104
166494
82423
SH
SOLE
82423
0
0
ACLARIS THERAPEUTICS INC
COM
00461U105
121693
115898
SH
SOLE
115898
0
0
ALPHABET INC
CAP STK CL C
02079K107
14093
100
SH
SOLE
100
0
0
AMYLYX PHARMACEUTICALS INC
COM
03237H101
206080
14000
SH
SOLE
14000
0
0
ARDELYX INC
COM
039697107
7140335
1151667
SH
SOLE
1151667
0
0
AVADEL PHARMACEUTICALS PLC
SPONSORED ADR
05337M104
1129600
80000
SH
SOLE
80000
0
0
BATTALION OIL CORPORATION
COM
07134L107
2135169
222182
SH
SOLE
222182
0
0
BLUEBIRD BIO INC
COM
09609G100
733133
531256
SH
SOLE
531256
0
0
BURGERFI INTERNATIONAL INC
COM
12122L101
2361232
2745938
SH
SOLE
2745938
0
0
BURGERFI INTERNATIONAL INC
*W EXP 12/16/202
12122L119
93755
2083438
SH
SOLE
2083438
0
0
CYMABAY THERAPEUTICS INC
COM
23257D103
1946879
82425
SH
SOLE
82425
0
0
ENPHYS ACQUISITION CORP
CL A ORD SHS
G3167L109
833594
78125
SH
SOLE
78125
0
0
FENNEC PHARMACEUTICALS INC
COM
31447P100
1234200
110000
SH
SOLE
110000
0
0
HARPOON THERAPEUTICS INC
COM NEW
41358P205
2602593
228900
SH
SOLE
228900
0
0
HUMACYTE INC
COM
44486Q103
667400
235000
SH
SOLE
235000
0
0
INSMED INC
COM PAR $.01
457669307
2179682
70335
SH
SOLE
70335
0
0
ISHARES TR
RUSSELL 2000 ETF
464287655
33117150
165000
SH
Put
SOLE
165000
0
0
KINIKSA PHARMACEUTICALS LTD
COM CL A
G5269C101
2292320
130691
SH
SOLE
130691
0
0
LUMOS PHARMA INC
COM
55028X109
288725
90794
SH
SOLE
90794
0
0
MARINUS PHARMACEUTICALS INC
COM NEW
56854Q200
23200243
2134337
SH
SOLE
2134337
0
0
MICROSOFT CORP
COM
594918104
37604
100
SH
SOLE
100
0
0
MILESTONE PHARMACEUTICALS IN
COM
59935V107
2755846
1650207
SH
SOLE
1650207
0
0
MIRUM PHARMACEUTICALS INC
COM
604749101
398520
13500
SH
SOLE
13500
0
0
REPLIMUNE GROUP INC
COM
76029N106
358275
42500
SH
SOLE
42500
0
0
SEMTECH CORP
COM
816850101
56480803
2577855
SH
SOLE
2577855
0
0
SEMTECH CORP
COM
816850101
54775000
2500000
SH
Call
SOLE
2500000
0
0
SERES THERAPEUTICS INC
COM
81750R102
477065
340761
SH
SOLE
340761
0
0
SYNDAX PHARMACEUTICALS INC
COM
87164F105
745545
34500
SH
SOLE
34500
0
0
TRAVERE THERAPEUTICS INC
COM
89422G107
701220
78000
SH
SOLE
78000
0
0
TRAVERE THERAPEUTICS INC
NOTE 2.250% 3/0
89422GAA5
670740
1000000
PRN
SOLE
1000000
0
0